Cargando…

Circulating CD133+CD34+ progenitor cells inversely correlate with soluble ICAM-1 in early ischemic stroke patients

BACKGROUND AND PURPOSE: Both endothelial progenitor cells (EPC) and markers of neuroinflammation are candidate biomarkers for stroke severity and outcome prediction. A relationship between EPC and neuroinflammatory markers in early stroke is not fully elucidated. The objectives were to investigate c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bogoslovsky, Tanya, Spatz, Maria, Chaudhry, Aneeka, Maric, Dragan, Luby, Marie, Frank, Joseph, Warach, Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179728/ https://www.ncbi.nlm.nih.gov/pubmed/21871109 http://dx.doi.org/10.1186/1479-5876-9-145

Ejemplares similares

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009)

Common molecular pathways involved in human CD133+/CD34+ progenitor cell expansion and cancer
por: Okamoto, Oswaldo Keith, et al.
Publicado: (2007)

Cryopreservation and Enumeration of Human Endothelial Progenitor and Endothelial Cells for Clinical Trials
por: Bogoslovsky, T, et al.
Publicado: (2013)

Viability and intracellular nitric oxide generation in the umbilical cord blood CD34(+)CD133(–) and CD34(+)CD133(+) cell populations exposed to local anaesthetics
por: Kulińska, Karolina I., et al.
Publicado: (2021)

Proteasomes Are Critical for Maintenance of CD133+CD24+ Kidney Progenitor Cells
por: Al-Marsoummi, Sarmad, et al.
Publicado: (2023)

Endothelial cells from cord blood CD133(+)CD34(+) progenitors share phenotypic, functional and gene expression profile similarities with lymphatics
por: Nguyen, Van Anh, et al.
Publicado: (2009)

Impact of Blood Vessel Quantity and Vascular Expression of CD133 and ICAM-1 on Survival of Glioblastoma Patients
por: Minajeva, Ave, et al.
Publicado: (2017)

CD271+, CXCR7+, CXCR4+, and CD133+ Stem/Progenitor Cells and Clinical Characteristics of Acute Ischemic Stroke Patients
por: Gójska-Grymajło, Anna, et al.
Publicado: (2018)

Combined Characterization of microRNA and mRNA Profiles Delineates Early Differentiation Pathways of CD133(+) and CD34(+) Hematopoietic Stem and Progenitor Cells
por: Bissels, Ute, et al.
Publicado: (2011)

Circulating CD133+/–CD34– Have Increased c-MYC Expression in Myeloproliferative Neoplasms
por: Uslu Bıçak, İldeniz, et al.
Publicado: (2023)

Mobilization of CD133(+) Progenitor Cells in Patients with Acute Cerebral Infarction
por: Sepp, Dominik, et al.
Publicado: (2014)

Identification of a CD133−CD55− population functions as a fetal common skeletal progenitor
por: Weng, Lihong, et al.
Publicado: (2016)

CD45(dim)CD34(+)CD38(−)CD133(+) cells have the potential as leukemic stem cells in acute myeloid leukemia
por: Heo, Sook-Kyoung, et al.
Publicado: (2020)

Phenotyping and Target Expression Profiling of CD34(+)/CD38(−) and CD34(+)/CD38(+) Stem- and Progenitor cells in Acute Lymphoblastic Leukemia
por: Blatt, Katharina, et al.
Publicado: (2018)

VCAM-1 expression is upregulated by CD34(+)/CD133(+)-stem cells derived from septic patients
por: Patry, Christian, et al.
Publicado: (2018)

Role of progenitor cell marker CD133 in supporting diagnosis of collapsing glomerulopathy
por: Xiao, Andrew Y., et al.
Publicado: (2022)

Adipocytokines and CD34(+) Progenitor Cells in Alzheimer's Disease
por: Bigalke, Boris, et al.
Publicado: (2011)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

Isolation of Murine Myeloid Progenitor Populations by CD34/CD150 Surface Markers
por: Olender, Leonid, et al.
Publicado: (2022)

Systemic Infusion of Expanded CD133(+) Cells and Expanded CD133(+) Cell-Derived EVs for the Treatment of Ischemic Cardiomyopathy in a Rat Model of AMI
por: Angulski, Addeli B. B., et al.
Publicado: (2019)

Analysis of cd45- [cd34+/kdr+] Endothelial Progenitor Cells as Juvenile Protective Factors in a Rat Model of Ischemic-Hemorrhagic Stroke
por: Decano, Julius L., et al.
Publicado: (2013)

Mobilization of CD34(+)-Progenitor Cells in Patients with Severe Trauma
por: Ritz, Ulrike, et al.
Publicado: (2014)

Osteoprotegerin Induces CD34(+) Differentiation in Endothelial Progenitor Cells
por: Boisson-Vidal, Catherine, et al.
Publicado: (2018)

Circulating CD133(+)VEGFR2(+) and CD34(+)VEGFR2(+) cells and arterial function in patients with beta-thalassaemia major
por: Cheung, Yiu-fai, et al.
Publicado: (2011)

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
por: Friel, Anne M, et al.
Publicado: (2010)

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
por: Grasso, Carole, et al.
Publicado: (2016)

A double blinded, placebo-controlled pilot study to examine reduction of CD34 (+)/CD117 (+)/CD133 (+) lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphoma
por: Ito, Daisuke, et al.
Publicado: (2017)

Human CD133-positive hematopoietic progenitor cells enhance the malignancy of breast cancer cells
por: Zhang, Zhe, et al.
Publicado: (2020)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

The CD133 and CD34 cell types in human umbilical cord blood have the capacity to produce infectious dengue virus particles
por: Vats, Amrita, et al.
Publicado: (2023)

CD34(+)/M-cadherin(+) Bone Marrow Progenitor Cells Promote Arteriogenesis in Ischemic Hindlimbs of ApoE(−/−) Mice
por: Terry, Toya, et al.
Publicado: (2011)

Human Pluripotent Stem Cells Differentiated in Fully Defined Medium Generate Hematopoietic CD34(+) and CD34(−) Progenitors with Distinct Characteristics
por: Chicha, Laurie, et al.
Publicado: (2011)

In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness
por: Brugnoli, Federica, et al.
Publicado: (2013)

Correction: Mobilization of CD34(+)-Progenitor Cells in Patients with Severe Trauma
Publicado: (2014)

Transient loading of CD34(+) hematopoietic progenitor cells with polystyrene nanoparticles
por: Deville, Sarah, et al.
Publicado: (2017)

CD34(+) progenitor cells as diagnostic and therapeutic targets in Alzheimer’s disease
por: Romaus-Sanjurjo, Daniel, et al.
Publicado: (2022)

CD34 positive cells as endothelial progenitor cells in biology and medicine
por: Hassanpour, Mehdi, et al.
Publicado: (2023)

Endothelial impairment and bone marrow‐derived CD34(+)/133(+) cells in diabetic patients with erectile dysfunction
por: Murata, Miho, et al.
Publicado: (2012)

Effects of pitavastatin on walking capacity and CD34(+)/133(+) cell number in patients with peripheral artery disease
por: Arao, Kenshiro, et al.
Publicado: (2017)

The Chemokine SDF-1 Is a Chemoattractant for Human CD34(+) Hematopoietic Progenitor Cells and Provides a New Mechanism to Explain the Mobilization of CD34(+) Progenitors to Peripheral Blood
por: Aiuti, A., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_8dce3i6jfpg7kmbqalfuiok359